微信关注
Total item
Cart Subtotal
￥ 0.00 产品详情
PLX4032(Vemurafenib)也称为RG7204，Vemurafenib，R7204，RO5185426。PLX4032是B-raf抑制剂，IC50为44 nM。
Targets
| Target | Value |
|---|---|
| SRMS | IC50: 18nM |
| ACK1 | IC50: 19nM |
| B-Raf(V600E) | IC50: 31nM |
| C-Raf | IC50: 48nM |
| MAP4K5(KHS1) | IC50: 51nM |
| FGR | IC50: 63nM |
| B-Raf | IC50: 100nM |
| LCK | IC50: 183nM |
| BRK | IC50: 213nM |
| NEK11 | IC50: 317nM |
| BLK | IC50: 547nM |
| LynB | IC50: 599nM |
| YES1 | IC50: 604nM |
| WNK3 | IC50: 877nM |
| MNK2 | IC50: 1.717μM |
| FRK(PTK5) | IC50: 1.884μM |
| CSK | IC50: 2.339μM |
| Src | IC50: 2.389μM |
| In vitro (25°C) | DMSO | 83 mg/mL (169.41 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
| In vivo | 4% DMSO+30% PEG 300+5% Tween 80+ddH2O (suspension) | 4 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 20.41 mL | 102.06 mL | 204.12 mL |
| 0.5 mM | 4.08 mL | 20.41 mL | 40.82 mL |
| 1 mM | 2.04 mL | 10.21 mL | 20.41 mL |
| 5 mM | 0.41 mL | 2.04 mL | 4.08 mL |
*The above data is based on the productmolecular weight 489.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| 目录号 | A10739 |
|---|---|
| 作用机制 | Inhibitor (抑制剂) |
| M. Wt | 489.9 |
| Formula | C23H18ClF2N3O3S |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| CAS No. | 918504-65-1 |
| Synonyms | RG7204,RO5185426,Zelboraf, PLX-4032 |
| SMILES | CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F |
产品资料
产品标签
Product Questions
Product Questions
No Questions
您还可能对下列产品感兴趣
RAF265 (CHIR-265)
RAF265 (CHIR-265)是一种口服，高度选择性的RAF和VEGFR激酶抑制剂，可控制或正常化VEGFR-2，同时抑制B-raf和c-Raf…
Dabrafenib (GSK2118436A)
Dabrafenib (GSK2118436A)是一种有效且选择性的B-RAF蛋白激酶抑制剂，具有V600E突变，目前正在临床试验中。
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506)是一种多激酶抑制剂，IC50为17、40和69 nM c-KIT，VEGFR2，B-Raf。Regorafenib（BAY 73-4506）是一种…
NVP-BHG712
NVP-BHG712是EphB4激酶的选择性抑制剂，在体外对EphB4的选择性超过40多种其他激酶（包括FGFR3）。
Dabigatran ethyl ester
Dabigatran ethyl ester是一种新兴的口服抗凝剂，是凝血酶活性的直接抑制剂。
Keywords:购买 PLX4032 (Vemurafenib) | PLX4032 (Vemurafenib) 供应商 | 订购 PLX4032 (Vemurafenib) | PLX4032 (Vemurafenib) 价格 | PLX4032 (Vemurafenib) 生产商 | 订单 PLX4032 (Vemurafenib) | PLX4032 (Vemurafenib) 代理商 | 购买 918504-65-1| 918504-65-1 供应商 | 订购 918504-65-1 | 918504-65-1 价格 | 918504-65-1 生产商 | 订单 918504-65-1 | 918504-65-1 代理商|buy PLX4032 (Vemurafenib) | PLX4032 (Vemurafenib) Supplier | purchase PLX4032 (Vemurafenib) | PLX4032 (Vemurafenib) cost | PLX4032 (Vemurafenib) manufacturer | order PLX4032 (Vemurafenib) | PLX4032 (Vemurafenib) distributor | buy 918504-65-1| 918504-65-1 Supplier | purchase 918504-65-1 | 918504-65-1 cost | 918504-65-1 manufacturer | order 918504-65-1 | 918504-65-1 distributor